Mednet Logo
CommunityMedical Oncology

What is your preferred third-line therapy for metastatic colon cancer, RAS-WT, MSS, low TMB, with no targetable alterations?

Are you using fruquintinib, regorafinib, or trifluridine + tipiracil + bev?
Community PollStarted

What is your preferred third line therapy for colon cancer?

148 physicians have voted

Join Mednetto vote and see how they answered.

2 Answers
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center
Answered on

My preferred treatment in this scenario is trifluridine-tipiracil plus bevacizumab. This is based on the favorable side-effect profile of this regimen (compared to alternatives) and the evidence from the SUNLIGHT trial, which showed that bevacizumab plus trifluridine-tipiracil was superior to triflu...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Henry Ford Cancer Institute (HFCI)
Answered on

If no clinical trial is available, then Lonsurf, Avastin, or at times, rechallenge with an anti-EGFR may be used in first line.

Join for free or sign in to see the full answer